Private Advisor Group, LLC P Lx Pharma Inc. Transaction History

Private Advisor Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.12 - $0.3 $1,556 - $3,891	12,970 Added 94.5%	26,695 $3,000
Q3 2022 Oct 14, 2022	SELL	$0.52 - $3.08 $312 - $1,848	-600 Reduced 4.19%	13,725 $9,000
Q2 2022 Jul 13, 2022	SELL	$1.9 - $4.18 $69,872 - $153,719	-36,775 Reduced 71.97%	14,325 $35,000
Q1 2022 May 12, 2022	BUY	$3.54 - $8.3 $70,357 - $164,962	19,875 Added 63.65%	51,100 $206,000
Q4 2021 Feb 10, 2022	BUY	$7.69 - $19.66 $13,457 - $34,405	1,750 Added 5.94%	31,225 $250,000

Q3 2021 Oct 14, 2021	BUY	$12.22 - $21.28 $53,768 - $93,632	4,400 Added 17.55%	29,475 $569,000
Q2 2021 Aug 12, 2021	BUY	$9.0 - $15.94 $13,950 - $24,707	1,550 Added 6.59%	25,075 $346,000
Q1 2021 Apr 22, 2021	BUY	$5.24 - $10.14 $123,271 - $238,543	23,525 New	23,525 $212,000
Q3 2020 Nov 02, 2020	SELL	$2.83 - $4.21 $70 - $105	-25 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$2.32 - $4.02 $57 - $100	25 New	25 $0

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.